Zhejiang Poly Pharmaceuticals' Injection and Solid Dosage Workshops Receive US FDA Certification

Zhejiang Poly Pharmaceuticals Co., Ltd. (hereinafter referred to as "Zhejiang Poly"), a wh...

View details

Poly Pharmaceuticals has successfully developed Ursodeoxycholic acid (UDCA) API and looks forward to exploring the global market together with you.

Poly Pharmaceuticals Successfully Develops Ursodeoxycholic Acid (UDCA) Raw MaterialPoly Pharmaceutic...

View details

Zhejiang Poly Pharmaceuticals Unleashes New Production Capacity - Oral Liquid Production Line Complies with US, EU, and Chinese GMP Requirements, Welcomes Collaboration of Domestic and International CDMO/CMO

Zhejiang Poly Pharmaceuticals is a wholly-owned subsidiary of Hainan Poly Pharmaceutical (stock code...

View details